Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
stock prices
Pharma
FDA’s Rasonque review documents pressure RevMed
FDA review documents released Thursday fueled investor anxiety over Rasonque’s performance in patients with KRAS G12D tumors.
Angus Liu
Oct 9, 2026 11:25am
Bayer stock crumbles after $2B Roundup loss in California
May 14, 2019 12:25pm
Phillip Frost pays $5.5M to settle SEC stock manipulation charges
Jan 2, 2019 12:16pm
What's next for Allergan? Depends on the pipeline: analysts
Jun 19, 2018 9:56am
FiercePharmaAsia—Takeda, WuXi AppTec and more
Jun 1, 2018 9:41am
China's Gardasil approvals spawn new billionaires: Bloomberg
May 31, 2018 11:27am
